首页 | 官方网站   微博 | 高级检索  
     

舒血宁联合曲美他嗪治疗冠心病心绞痛临床观察
引用本文:刘东敏.舒血宁联合曲美他嗪治疗冠心病心绞痛临床观察[J].中国实验方剂学杂志,2011,17(19):258-260.
作者姓名:刘东敏
作者单位:陕西中医学院附属医院心内科,陕西成阳,712000
摘    要:目的:观察舒血宁和曲美他嗪治疗冠心病心绞痛的临床疗效。方法:将120例冠心病心绞痛患者随机分为治疗组和对照组,对照组给予西药常规治疗,治疗组加用舒血宁联合曲美他嗪。4周为1个疗程。结果:症状疗效对照组总有效率为85.00%,治疗组总有效率98.33%(P<0.05);对照组心电图改善总有效率60.00%,治疗组总有效率为85.00%(P<0.05);两组治疗后总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)较治疗前下降,高密度脂蛋白胆固醇(HDL-C)较治疗前升高,并且治疗组较对照组改善更明显(P<0.05)。结论:舒血宁联合曲美他嗪治疗冠心病心绞痛疗效显著。

关 键 词:舒血宁  曲美他嗪  冠心病  心绞痛
收稿时间:4/7/2011 12:00:00 AM

Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris
LIU Dong-min.Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris[J].China Journal of Experimental Traditional Medical Formulae,2011,17(19):258-260.
Authors:LIU Dong-min
Affiliation:Department of Cardiology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, China
Abstract:Objective:To observe the therapeutic effect of the Shuxuening injection and Trimetazidine on coronary heart disease(CHD)and angina pectoris.Method: One hundred and twenty patients were randomly divided into treatment group and control group.The control group were given routine western medicine,and the treatment group received Shuxuening injection and trimetazidine additionally.4 weeks was a course of treatment.Result: The total effective rate was 85.00% in control group and 98.33% in treatment group on the ...
Keywords:Shuxuening injection  trimetazidine  coronary heart disease  angina pectoris  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号